View in EDS

Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).

Saved in:
Bibliographic Details
Title: Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).
Authors: Nakamura Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Yamazaki N; Department of Dermatologic Oncology, National Cancer Centre Hospital, Tokyo, Japan., Namikawa K; Department of Dermatologic Oncology, National Cancer Centre Hospital, Tokyo, Japan., Uchi H; Department of Dermato-Oncology, National Hospital Organisation Kyushu Cancer Centre, Fukuoka, Japan., Mori S; Department of Dermatology, Nagoya University Graduate School of Medicine, Aichi, Japan., Ogawa-Momohara M; Department of Dermatology, Nagoya University Graduate School of Medicine, Aichi, Japan., Fujimura T; Department of Dermatology, Tohoku University School of Medicine, Miyagi, Japan., Takenouchi T; Division of Dermatology, Niigata Cancer Centre Hospital, Niigata, Japan., Kurimoto M; Department of Dermatology, Wakayama Medical University, Wakayama, Japan., Yamamoto Y; Department of Dermatology, Wakayama Medical University, Wakayama, Japan., Otsuka A; Department of Dermatology, Kyoto University School of Medicine, Kyoto, Japan., Kabashima K; Department of Dermatology, Kyoto University School of Medicine, Kyoto, Japan., Fusumae T; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Hirai I; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Tanese K; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.; Department of Dermatology, Toho University School of Medicine, Tokyo, Japan., Saito Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Amagai M; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Takemura R; Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical Translational Research Centre, Keio University School of Medicine, Tokyo, Japan., Sato Y; Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical Translational Research Centre, Keio University School of Medicine, Tokyo, Japan., Funakoshi T; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. takeruf@keio.jp.
Source: BMC cancer [BMC Cancer] 2026 Mar 04; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 04.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41781908
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nakamura+Y%22">Nakamura Y</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+N%22">Yamazaki N</searchLink>; Department of Dermatologic Oncology, National Cancer Centre Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Namikawa+K%22">Namikawa K</searchLink>; Department of Dermatologic Oncology, National Cancer Centre Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Uchi+H%22">Uchi H</searchLink>; Department of Dermato-Oncology, National Hospital Organisation Kyushu Cancer Centre, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Mori+S%22">Mori S</searchLink>; Department of Dermatology, Nagoya University Graduate School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Ogawa-Momohara+M%22">Ogawa-Momohara M</searchLink>; Department of Dermatology, Nagoya University Graduate School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Fujimura+T%22">Fujimura T</searchLink>; Department of Dermatology, Tohoku University School of Medicine, Miyagi, Japan.<br /><searchLink fieldCode="AU" term="%22Takenouchi+T%22">Takenouchi T</searchLink>; Division of Dermatology, Niigata Cancer Centre Hospital, Niigata, Japan.<br /><searchLink fieldCode="AU" term="%22Kurimoto+M%22">Kurimoto M</searchLink>; Department of Dermatology, Wakayama Medical University, Wakayama, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; Department of Dermatology, Wakayama Medical University, Wakayama, Japan.<br /><searchLink fieldCode="AU" term="%22Otsuka+A%22">Otsuka A</searchLink>; Department of Dermatology, Kyoto University School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Kabashima+K%22">Kabashima K</searchLink>; Department of Dermatology, Kyoto University School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Fusumae+T%22">Fusumae T</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hirai+I%22">Hirai I</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tanese+K%22">Tanese K</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.; Department of Dermatology, Toho University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+Y%22">Saito Y</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Amagai+M%22">Amagai M</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takemura+R%22">Takemura R</searchLink>; Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical Translational Research Centre, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+Y%22">Sato Y</searchLink>; Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical Translational Research Centre, Keio University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Funakoshi+T%22">Funakoshi T</searchLink>; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. takeruf@keio.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2026 Mar 04; Vol. 26 (1). <i>Date of Electronic Publication: </i>2026 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41781908
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-026-15829-2
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nakamura Y
      – PersonEntity:
          Name:
            NameFull: Yamazaki N
      – PersonEntity:
          Name:
            NameFull: Namikawa K
      – PersonEntity:
          Name:
            NameFull: Uchi H
      – PersonEntity:
          Name:
            NameFull: Mori S
      – PersonEntity:
          Name:
            NameFull: Ogawa-Momohara M
      – PersonEntity:
          Name:
            NameFull: Fujimura T
      – PersonEntity:
          Name:
            NameFull: Takenouchi T
      – PersonEntity:
          Name:
            NameFull: Kurimoto M
      – PersonEntity:
          Name:
            NameFull: Yamamoto Y
      – PersonEntity:
          Name:
            NameFull: Otsuka A
      – PersonEntity:
          Name:
            NameFull: Kabashima K
      – PersonEntity:
          Name:
            NameFull: Fusumae T
      – PersonEntity:
          Name:
            NameFull: Hirai I
      – PersonEntity:
          Name:
            NameFull: Tanese K
      – PersonEntity:
          Name:
            NameFull: Saito Y
      – PersonEntity:
          Name:
            NameFull: Amagai M
      – PersonEntity:
          Name:
            NameFull: Takemura R
      – PersonEntity:
          Name:
            NameFull: Sato Y
      – PersonEntity:
          Name:
            NameFull: Funakoshi T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 03
              Text: 2026 Mar 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1